Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

NCT06045247 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Large B-cell Lymphoma

Interventions

DRUG: Prednisone
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Epcoritamab

Sponsor

M.D. Anderson Cancer Center